Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jul 15;100(2):357–363. doi: 10.1172/JCI119541

Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.

I Shimon 1, X Yan 1, D W Ray 1, S Melmed 1
PMCID: PMC508198  PMID: 9218512

Abstract

We have shown recently that leukemia inhibitory factor (LIF) and oncostatin M (OSM), two members of the gp130-dependent cytokine family, stimulate murine proopiomelanocortin (POMC) transcription and adrenocorticotropin hormone (ACTH) secretion. LIF and corticotropin-releasing hormone (CRH) also synergistically induced in vivo ACTH secretion in fetal nonhuman primates. To elucidate the role of the gp130-related cytokines in human pituitary hormone regulation, we tested expression of gp130-related cytokine receptors in human fetal pituitaries. Using RT-PCR, mRNA expression of receptors for LIF, IL-6, and CRH, and the gp130 subunit, were all detected in fetal pituitaries of 18- and 31-wk gestation. Recombinant human IL-6, LIF, and OSM treatments of primary human fetal pituitary cultures (16-31 wk) increased ACTH secretion by up to 48% (P < 0.05) using doses of 1 nM, and when fetal cultures were cotreated with CRH, ACTH was induced five- to sixfold as compared to CRH alone (three- to fourfold; P = 0.01). Incubation with gp130-specific antibody suppressed basal and cytokine-stimulated ACTH secretion (alone or with CRH) from human fetal cells. Human POMC promoter -879/+6 fused to the luciferase reporter gene and transfected into AtT-20 cells, was stimulated by LIF (7-fold), which also exerted strong (22-fold) synergy with CRH on POMC transcription. Growth hormone (GH) release from fetal cultures was modestly stimulated (15-31%, P < 0.05), while other anterior pituitary hormones were not altered by these cytokines. Thus, physiologic concentrations of the gp130-related cytokines have direct effects on ACTH and GH regulation in the human pituitary, indicating that gp130-dependent signals serve as a paracrine system controlling early human pituitary function.

Full Text

The Full Text of this article is available as a PDF (272.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akita S., Conn P. M., Melmed S. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function. J Clin Endocrinol Metab. 1996 Nov;81(11):4170–4178. doi: 10.1210/jcem.81.11.8923879. [DOI] [PubMed] [Google Scholar]
  2. Akita S., Malkin J., Melmed S. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology. 1996 Jul;137(7):3140–3143. doi: 10.1210/endo.137.7.8770940. [DOI] [PubMed] [Google Scholar]
  3. Akita S., Webster J., Ren S. G., Takino H., Said J., Zand O., Melmed S. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest. 1995 Mar;95(3):1288–1298. doi: 10.1172/JCI117779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arzt E., Stelzer G., Renner U., Lange M., Müller O. A., Stalla G. K. Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest. 1992 Nov;90(5):1944–1951. doi: 10.1172/JCI116072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Asa S. L., Kovacs K., Singer W. Human fetal adenohypophysis: morphologic and functional analysis in vitro. Neuroendocrinology. 1991 Jun;53(6):562–572. doi: 10.1159/000125775. [DOI] [PubMed] [Google Scholar]
  6. Benigni F., Fantuzzi G., Sacco S., Sironi M., Pozzi P., Dinarello C. A., Sipe J. D., Poli V., Cappelletti M., Paonessa G. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood. 1996 Mar 1;87(5):1851–1854. [PubMed] [Google Scholar]
  7. Bousquet C., Ray D. W., Melmed S. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem. 1997 Apr 18;272(16):10551–10557. doi: 10.1074/jbc.272.16.10551. [DOI] [PubMed] [Google Scholar]
  8. Carmeliet P., Vankelecom H., Van Damme J., Billiau A., Denef C. Release of interleukin-6 from anterior pituitary cell aggregates: developmental pattern and modulation by glucocorticoids and forskolin. Neuroendocrinology. 1991 Jan;53(1):29–34. doi: 10.1159/000125693. [DOI] [PubMed] [Google Scholar]
  9. Chrousos G. P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995 May 18;332(20):1351–1362. doi: 10.1056/NEJM199505183322008. [DOI] [PubMed] [Google Scholar]
  10. Cochet M., Chang A. C., Cohen S. N. Characterization of the structural gene and putative 5'-regulatory sequences for human proopiomelanocortin. Nature. 1982 May 27;297(5864):335–339. doi: 10.1038/297335a0. [DOI] [PubMed] [Google Scholar]
  11. DeNoto F. M., Moore D. D., Goodman H. M. Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. Nucleic Acids Res. 1981 Aug 11;9(15):3719–3730. doi: 10.1093/nar/9.15.3719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. doi: 10.1126/science.1542794. [DOI] [PubMed] [Google Scholar]
  13. Gearing D. P. The leukemia inhibitory factor and its receptor. Adv Immunol. 1993;53:31–58. doi: 10.1016/s0065-2776(08)60497-6. [DOI] [PubMed] [Google Scholar]
  14. Gearing D. P., Thut C. J., VandeBos T., Gimpel S. D., Delaney P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991 Oct;10(10):2839–2848. doi: 10.1002/j.1460-2075.1991.tb07833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990 Dec 21;63(6):1149–1157. doi: 10.1016/0092-8674(90)90411-7. [DOI] [PubMed] [Google Scholar]
  16. Imura H., Fukata J., Mori T. Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol (Oxf) 1991 Aug;35(2):107–115. doi: 10.1111/j.1365-2265.1991.tb03506.x. [DOI] [PubMed] [Google Scholar]
  17. Ip N. Y., Nye S. H., Boulton T. G., Davis S., Taga T., Li Y., Birren S. J., Yasukawa K., Kishimoto T., Anderson D. J. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell. 1992 Jun 26;69(7):1121–1132. doi: 10.1016/0092-8674(92)90634-o. [DOI] [PubMed] [Google Scholar]
  18. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 1994 Jan 28;76(2):253–262. doi: 10.1016/0092-8674(94)90333-6. [DOI] [PubMed] [Google Scholar]
  19. Koenig J. I., Snow K., Clark B. D., Toni R., Cannon J. G., Shaw A. R., Dinarello C. A., Reichlin S., Lee S. L., Lechan R. M. Intrinsic pituitary interleukin-1 beta is induced by bacterial lipopolysaccharide. Endocrinology. 1990 Jun;126(6):3053–3058. doi: 10.1210/endo-126-6-3053. [DOI] [PubMed] [Google Scholar]
  20. Liu J., Modrell B., Aruffo A., Marken J. S., Taga T., Yasukawa K., Murakami M., Kishimoto T., Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem. 1992 Aug 25;267(24):16763–16766. [PubMed] [Google Scholar]
  21. Lyson K., McCann S. M. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology. 1991 Sep;54(3):262–266. doi: 10.1159/000125884. [DOI] [PubMed] [Google Scholar]
  22. Mastorakos G., Chrousos G. P., Weber J. S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab. 1993 Dec;77(6):1690–1694. doi: 10.1210/jcem.77.6.8263159. [DOI] [PubMed] [Google Scholar]
  23. Mastorakos G., Weber J. S., Magiakou M. A., Gunn H., Chrousos G. P. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab. 1994 Oct;79(4):934–939. doi: 10.1210/jcem.79.4.7962300. [DOI] [PubMed] [Google Scholar]
  24. Matta S. G., Weatherbee J., Sharp B. M. A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1 beta. Neuroendocrinology. 1992 Oct;56(4):516–525. doi: 10.1159/000126269. [DOI] [PubMed] [Google Scholar]
  25. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L. S., Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996 Dec 20;271(51):32635–32643. doi: 10.1074/jbc.271.51.32635. [DOI] [PubMed] [Google Scholar]
  26. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 1993 Jun 18;260(5115):1808–1810. doi: 10.1126/science.8511589. [DOI] [PubMed] [Google Scholar]
  27. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K., Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun. 1988 Sep 30;155(3):1459–1463. doi: 10.1016/s0006-291x(88)81305-6. [DOI] [PubMed] [Google Scholar]
  28. Navarra P., Tsagarakis S., Faria M. S., Rees L. H., Besser G. M., Grossman A. B. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology. 1991 Jan;128(1):37–44. doi: 10.1210/endo-128-1-37. [DOI] [PubMed] [Google Scholar]
  29. Orth D. N. Corticotropin-releasing hormone in humans. Endocr Rev. 1992 May;13(2):164–191. doi: 10.1210/edrv-13-2-164. [DOI] [PubMed] [Google Scholar]
  30. Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995 May 5;270(18):10915–10922. doi: 10.1074/jbc.270.18.10915. [DOI] [PubMed] [Google Scholar]
  31. Ray D. W., Ren S. G., Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest. 1996 Apr 15;97(8):1852–1859. doi: 10.1172/JCI118615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rivier C., Vale W., Brown M. In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release. Endocrinology. 1989 Dec;125(6):3096–3102. doi: 10.1210/endo-125-6-3096. [DOI] [PubMed] [Google Scholar]
  33. Shimon I., Taylor J. E., Dong J. Z., Bitonte R. A., Kim S., Morgan B., Coy D. H., Culler M. D., Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest. 1997 Feb 15;99(4):789–798. doi: 10.1172/JCI119225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Spangelo B. L., Judd A. M., Isakson P. C., MacLeod R. M. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology. 1989 Jul;125(1):575–577. doi: 10.1210/endo-125-1-575. [DOI] [PubMed] [Google Scholar]
  35. Spangelo B. L., deHoll P. D., Kalabay L., Bond B. R., Arnaud P. Neurointermediate pituitary lobe cells synthesize and release interleukin-6 in vitro: effects of lipopolysaccharide and interleukin-1 beta. Endocrinology. 1994 Aug;135(2):556–563. doi: 10.1210/endo.135.2.8033802. [DOI] [PubMed] [Google Scholar]
  36. Spinedi E., Hadid R., Daneva T., Gaillard R. C. Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action. Neuroendocrinology. 1992 Jul;56(1):46–53. doi: 10.1159/000126207. [DOI] [PubMed] [Google Scholar]
  37. Späth-Schwalbe E., Born J., Schrezenmeier H., Bornstein S. R., Stromeyer P., Drechsler S., Fehm H. L., Porzsolt F. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J Clin Endocrinol Metab. 1994 Oct;79(4):1212–1214. doi: 10.1210/jcem.79.4.7962296. [DOI] [PubMed] [Google Scholar]
  38. Stahl N., Yancopoulos G. D. The alphas, betas, and kinases of cytokine receptor complexes. Cell. 1993 Aug 27;74(4):587–590. doi: 10.1016/0092-8674(93)90506-l. [DOI] [PubMed] [Google Scholar]
  39. Stefana B., Ray D. W., Melmed S. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12502–12506. doi: 10.1073/pnas.93.22.12502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989 Aug 11;58(3):573–581. doi: 10.1016/0092-8674(89)90438-8. [DOI] [PubMed] [Google Scholar]
  41. Taga T., Narazaki M., Yasukawa K., Saito T., Miki D., Hamaguchi M., Davis S., Shoyab M., Yancopoulos G. D., Kishimoto T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10998–11001. doi: 10.1073/pnas.89.22.10998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Thoma B., Bird T. A., Friend D. J., Gearing D. P., Dower S. K. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem. 1994 Feb 25;269(8):6215–6222. [PubMed] [Google Scholar]
  43. Vankelecom H., Carmeliet P., Van Damme J., Billiau A., Denef C. Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology. 1989 Jan;49(1):102–106. doi: 10.1159/000125097. [DOI] [PubMed] [Google Scholar]
  44. Vankelecom H., Matthys P., Van Damme J., Heremans H., Billiau A., Denef C. Immunocytochemical evidence that S-100-positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity. J Histochem Cytochem. 1993 Feb;41(2):151–156. doi: 10.1177/41.2.8419456. [DOI] [PubMed] [Google Scholar]
  45. Velkeniers B., Vergani P., Trouillas J., D'Haens J., Hooghe R. J., Hooghe-Peters E. L. Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas. J Histochem Cytochem. 1994 Jan;42(1):67–76. doi: 10.1177/42.1.8263325. [DOI] [PubMed] [Google Scholar]
  46. Vita N., Laurent P., Lefort S., Chalon P., Lelias J. M., Kaghad M., Le Fur G., Caput D., Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett. 1993 Nov 29;335(1):1–5. doi: 10.1016/0014-5793(93)80427-v. [DOI] [PubMed] [Google Scholar]
  47. Wang Z., Ren S. G., Melmed S. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology. 1996 Jul;137(7):2947–2953. doi: 10.1210/endo.137.7.8770918. [DOI] [PubMed] [Google Scholar]
  48. Woloski B. M., Smith E. M., Meyer W. J., 3rd, Fuller G. M., Blalock J. E. Corticotropin-releasing activity of monokines. Science. 1985 Nov 29;230(4729):1035–1037. doi: 10.1126/science.2997929. [DOI] [PubMed] [Google Scholar]
  49. Yamaguchi M., Matsuzaki N., Hirota K., Miyake A., Tanizawa O. Interleukin 6 possibly induced by interleukin 1 beta in the pituitary gland stimulates the release of gonadotropins and prolactin. Acta Endocrinol (Copenh) 1990 Feb;122(2):201–205. doi: 10.1530/acta.0.1220201. [DOI] [PubMed] [Google Scholar]
  50. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science. 1988 Aug 12;241(4867):825–828. doi: 10.1126/science.3136546. [DOI] [PubMed] [Google Scholar]
  51. Yin T., Taga T., Tsang M. L., Yasukawa K., Kishimoto T., Yang Y. C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol. 1993 Sep 1;151(5):2555–2561. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES